Increase in Pneumococcus Macrolide Resistance, United States

During year 6 of the study, the incidence rate rose from ≈30% to 35.3%.

• Publication year

  2009

• Venue

  Emerging Infectious Diseases

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3201/eid1508.081187PMID 19751588PMCID 2815953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New York Presbyterian Hospital, Weill Cornell Medical College

  2010cited by this paper
• Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement

  2008cited by this paper
• Clinical impact of antibiotic resistance in respiratory tract infections.

  2007cited by this paper
• Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.

  2007cited by this paper
• Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).

  2007cited by this paper
• Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.

  2007cited by this paper
• Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001–2005)

  2007cited by this paper
• National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance Study

  2007cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Macrolide resistance in bacteremic pneumococcal disease: implications for patient management.

  2006cited by this paper
• Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.

  2006cited by this paper
• Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus pneumoniae

  2006cited by this paper
• Prevalence and Antibacterial Susceptibility of mef(A)-Positive Macrolide-Resistant Streptococcus pneumoniae over 4 Years (2000 to 2004) of the PROTEKT US Study

  2006cited by this paper
• Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.

  2005cited by this paper
• Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance

  2005cited by this paper
• Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

  2005cited by this paper
• Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.

  2004cited by this paper
• Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.

  2003cited by this paper
• Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.

  2002cited by this paper
• Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.

  2002cited by this paper
• Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

  2001cited by this paper
• The epidemiology of respiratory tract infections.

  2000influential reference
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

  1999cited by this paper

• Azithromycin use for common acute respiratory infections during a Mycoplasma pneumoniae national surge: results from the SHARPS-OP benchmarking collaborative.

  2026cites this paper
• Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System

  2026cites this paper
• Comparison of antimicrobial resistance genes on the ocular surface of patients with corneal infections in California and Malawi

  2025cites this paper
• Antibiotic resistance of E. coli isolates from different water sources in Mbarara, Uganda.

  2024cites this paper
• Antibiotic prescription for outpatients with influenza and subsequent hospitalisation: A cohort study using insurance data

  2023cites this paper
• Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis

  2022cites this paper
• Antibiotic Stewardship und chronische Lungenerkrankungen

  2022cites this paper
• Antibiotic Prescription Patterns in the Paediatric Primary Care Setting before and after the COVID-19 Pandemic in Italy: An Analysis Using the AWaRe Metrics

  2022cites this paper
• Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia

  2022cites this paper
• Increase in Penicillin and multidrug resistance in Streptococcus pneumoniae (1993-2016): Report from a tertiary care hospital laboratory, Pakistan.

  2021cites this paper
• A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States

  2021cites this paper
• Streptococcus pneumoniae (MS 00057)

  2020cites this paper
• Evaluation of pharmacist-led strategy to reduce outpatient fluoroquinolone prescribing from the emergency department.

  2020cites this paper
• Characterization of the resistome and microbiome of retail meats processed from carcasses of conventionally and naturally raised cattle

  2020cites this paper
• Molecular Analysis of PBP1A in Streptococcus pneumoniae Isolated from Clinical and Normal Flora Samples in Tehran, Iran: A Multicenter Study

  2019cites this paper
• Impact of an Antibiotic Stewardship Program on Antibiotic Prescription for Acute Respiratory Tract Infections in Children: A Prospective Before-After Study

  2019cites this paper
• Macrolides induce severe cardiotoxicity and developmental toxicity in zebrafish embryos.

  2019cites this paper
• Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM)

  2019cites this paper
• Impact of Beta-Lactam Allergy on Treatment of Outpatient Infections.

  2019cites this paper
• International prevalence and risk factors evaluation for Drug-Resistant Streptococcus pneumoniae pneumonia.

  2019cites this paper
• Antimicrobial Resistance Among Streptococcus pneumoniae

  2018cites this paper
• Macrolide Resistance in Cases of Community-Acquired Bacterial Pneumonia in the Emergency Department.

  2018cites this paper
• Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial

  2018cites this paper
• A Simple Approach to Pneumococcal Vaccination in Adults

  2018cites this paper
• Antimicrobial Stewardship in the Emergency Department.

  2018cites this paper
• Prevalence of pneumococcal serotypes in adults ≥50 years of age

  2017cites this paper
• Spatial and seasonal analysis of antimicrobials and toxicity tests with Daphnia magna, on the sub-basin of Piracicaba river, SP, Brazil

  2017cites this paper
• Community-acquired pneumonia in Malawian adults: Aetiology and predictors of mortality.

  2017cites this paper
• In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

  2017cites this paper
• Sepsis National Hospital Inpatient Quality Measure (SEP-1): Multistakeholder Work Group Recommendations for Appropriate Antibiotics for the Treatment of Sepsis.

  2017cites this paper
• Risk Factors for Outpatient Use of Antibiotics in Children with Acute Respiratory Illnesses

  2017cites this paper
• Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015

  2017cites this paper
• Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications

  2017cites this paper
• Resistance to Macrolide Antibiotics in Public Health Pathogens.

  2016cites this paper
• Macrolide Resistance Phenotype among the Tetracycline-Resistant Isolates of Streptococcus Pneumoniae

  2016cites this paper
• Polymicrobial community‐acquired pneumonia: An emerging entity

  2016cites this paper
• The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.

  2015influential citation
• Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan

  2015cites this paper
• for in the Population A Cross-sectional

  2015cites this paper
• Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population

  2015cites this paper
• Antibiotic prescribing for respiratory infections at retail clinics, physician practices, and emergency departments.

  2015cites this paper
• Factors associated with empyema in children with community acquired pneumonia.

  2015cites this paper
• Special phenotypic methods for detecting antibacterial resistance.

  2015cites this paper
• Mobile Elements and Chromosomal Changes Associated with MLS Resistance Phenotypes of Invasive Pneumococci Recovered in the United States

  2015cites this paper
• Canadian Pediatricians’ Prescribing Practices for Community-Acquired Pneumonia

  2014cites this paper
• Model Pharmacodynamic In Vitro Biofilms in an Induced Streptococcus pneumoniae Antibiotic Activity against Naive and

  2014cites this paper
• Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics

  2014cites this paper
• Distribution of macrolide-resistant genes among isolates of macrolideresistant Streptococcus pyogenes and Streptococcus pneumoniae in Serbia

  2014cites this paper
• Gradenigo Syndrome: Unusual Consequence of Otitis Media

  2014cites this paper
• Genotypic characterization of Streptococcus pneumoniae serotype 19F in Malaysia.

  2014cites this paper
• High burden of antimicrobial drug resistance in Asia.

  2014cites this paper
• Long-term macrolide therapy in chronic obstructive pulmonary disease

  2014cites this paper
• Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.

  2013cites this paper
• Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics

  2013cites this paper
• Judicious use of antibiotics to minimize emerging resistance: the macrolide clarithromycin as a case study

  2013cites this paper
• SPECTROPHOTOMETRIC DETERMINATION OF ANTIBIOTICS IN PHARMACEUTICAL PRODUCTS WITH TURBIDIMETRY METHOD BY USINGPB 4+ AND TANGESTO PHOSPHORIC ACID

  2013influential citation
• Functionally Cloned pdrM from Streptococcus pneumoniae Encodes a Na+ Coupled Multidrug Efflux Pump

  2013cites this paper
• Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center

  2013cites this paper
• Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.

  2013cites this paper
• Antibiotic Activity against Naive and Induced Streptococcus pneumoniae Biofilms in an In Vitro Pharmacodynamic Model

  2013cites this paper
• The Changing Microbiologic Epidemiology of Community-Acquired Pneumonia

  2013cites this paper
• Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates.

  2013cites this paper
• Advances in pneumococcal antibiotic resistance

  2013cites this paper
• Molecular Resistance Mechanisms of Macrolide-Resistant Invasive Streptococcus pneumoniae Isolates from Alaska, 1986 to 2010

  2013cites this paper
• Should Amoxicillin Versus Amoxicillin-Clavulanate Be Used for Initial Empiric Antimicrobial Therapy of ABRS in Children ?

  2012cites this paper
• Some think antibiotics are candy, but we know they're not: answers to the May 2012 Journal Club Questions.

  2012cites this paper
• IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.

  2012cites this paper
• Pneumonia Due to Drug-Resistant Streptococcus pneumoniae

  2012cites this paper
• Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece

  2012cites this paper
• Current concepts in laboratory testing to guide antimicrobial therapy.

  2012cites this paper
• The relationship between pneumococcal serotypes and antibiotic resistance.

  2012cites this paper
• Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

  2012cites this paper
• Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

  2012cites this paper
• Current and future challenges in the development of antimicrobial agents.

  2012cites this paper
• Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

  2012cites this paper
• Some think antibiotics are candy, but we know they're not.

  2012cites this paper
• 290 – Mechanisms and Detection of Antimicrobial Resistance

  2012cites this paper
• Should Amoxicillin Versus Amoxicillin-Clavulanate Be Used for Initial Empiric Antimicrobial Therapy of ABRS in Children ?

  2012cites this paper
• Synthesis and antibacterial activity of novel 4-aryl-[1,2,3]-triazole containing macrolides.

  2011cites this paper
• Evaluación de la actividad de diferentes antimicrobianos frente a Streptococcus pneumoniae provenientes de pacientes adultos con neumonía adquirida en la comunidad

  2011cites this paper
• Treatment of bacterial conjunctivitis in children.

  2011cites this paper
• High burden of antimicrobial resistance in Asia.

  2011cites this paper
• Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline).

  2011cites this paper
• Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.

  2011cites this paper
• Evaluation of Disk Approximation and Single-Well Broth Tests for Detection of Inducible Clindamycin Resistance in Streptococcus pneumoniae

  2011cites this paper
• Induction of Efflux-Mediated Macrolide Resistance in Streptococcus pneumoniae

  2011cites this paper
• Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.

  2011cites this paper
• [Increase in erythromycin-resistant Streptococcus pneumoniae in Colombia, 1994-2008].

  2011cites this paper
• Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.

  2011cites this paper
• Macrolide overuse for treatment of respiratory tract infections in general practice.

  2011cites this paper
• Serotype Emergence and Genotype Distribution among Macrolide-Resistant Invasive Streptococcus Pneumoniae Isolates in the Postconjugate Vaccine (PCV-7) Era

  2011cites this paper
• LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States

  2011cites this paper
• Incremento de la resistencia a eritromicina de Streptococcus pneumoniae, Colombia, 1994-2008

  2011influential citation
• Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis

  2010cites this paper
• Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae

  2010cites this paper
• Increase in Pneumococcus Macrolide Resistance, USA

  2010influential citation
• Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis

  2010cites this paper
• Feedback to internal medicine ward physicians from multidisciplinary antimicrobial use teams improves appropriate antimicrobial use

  2010cites this paper
• Rapid Antigen Test for Pandemic (H1N1) 2009 Virus

  2010cites this paper
• Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors

  2010cites this paper